Dr. Ejaz received her Doctor of Pharmacy degree from the University of Cincinnati James L. Winkle College of Pharmacy. After obtaining her degree, she completed an ASHP-accredited Pharmacy Practice Residency at The University Hospital, Cincinnati, OH. She also completed a second year residency and fellowship in solid organ transplant pharmacy at the University of Cincinnati Medical Center, Cincinnati, OH. Following completion of her post-doctoral training, she obtained her current position as a Research Assistant Professor at the University of Cincinnati Medical Center.
Dr. Ejaz is currently serving on the Board of Directors for the IPITTR. She serves as a reviewer and assists in providing consultative services for the Registry. She also conducts research projects using Registry data. Her most current project with the Registry is conducting an analysis on 285 patients with preexisting renal cell carcinoma to determine the effect of transplantation on the risk of cancer recurrence.
Dr. Ejaz’s individual research efforts focus specifically on antihumoral therapy. She has recently published on the toxicity profile of bortezomib in transplant candidates and recipients. She has several awards for her research in transplantation, including the Young Investigators Award for the American Transplant Congress (ATC) in 2011 and 2012, the ATC Pharmacist Community of Practice Best New Practitioner Research Project Travel Award 2012, and the American College of Clinical Pharmacy Immunology/Transplantation Practice Research Network Travel Award 2010. She is currently a member of the American Society of Transplantation.